Exciting news from Health Canada! Tzield has received approval, making history as the first-ever disease-modifying therapy for type 1 diabetes. This revolutionary treatment brings a wave of hope to patients, with the potential to not only halt disease progression but also significantly improve their quality of life.
Exciting news from Health Canada! They’ve broadened the approval of Jemperli (dostarlimab) in combination with chemotherapy for all adults facing primary advanced or first recurrent endometrial cancer. This groundbreaking treatment is the first in immuno-oncology to show a remarkable overall survival benefit.
bioMérieux has announced that it has received Health Canada approval for its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel. This diagnostic tool aims to enhance rapid testing for respiratory infections, providing efficient solutions for patient care in Canada.
